Document is current
Any future updates will be listed below
-
Authors
Rao, Lubei
Xu, Pingyao
Zhang, Guiji
Zu, Ruiling
Luo, Yajun
Zhang, Kaijiong
Yang, Ying
Wang, Dongsheng
He, Shuya
Luo, Huaichao
Ye, Bo
-
Funding
Funding for this research was provided by:
Research Found of Health Commission of Sichuan Provincial (21PJ117)
Natural Science Foundation of Sichuan Province (22NSFSC1284)
Youth of Sichuan Science and Technology Program (2023NSFSC1896)
Key R&D Project of Sichuan Provincial Department of Science and Technology (2022ZYF1927)
Key R&D Project of Chengdu Science and Technology Bureau (YF05-01792-SN)
- License Information
-
More Information
Article History
Received: 8 November 2023
Accepted: 23 April 2024
First Online: 29 April 2024
Declarations
:
: The authors have no relevant financial or non-financial interests to disclose.
: The research related to human use has complied with all the relevant national regulations, institutional policies and follows the tenets of the Helsinki Declaration, and has been approved by the Institutional Ethics Committee of The Sichuan Cancer Hospital. The Institutional Review Board (IRB) of the Sichuan Cancer Hospital approved this retrospective study (IRB code: SCCHEC-02-2022-017). This retrospective study has been approved to waive informed consent by the Institutional Review Board of the Sichuan Cancer Hospital.
: The study was a retrospective analysis and didn’t require the patient’s informed consent.
: Not applicable.
